1. Market Research
  2. > General Medicine And Specialty Medicine Industry
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Oncology Industry, December 2016 Market Reports from Top Publishers

You might be interested in: Therapy, Cancer, Pharmaceutical, Biosimilar, Healthcare, Molecular Diagnostic, Diagnostics, Clinical Trial, In Vitro Diagnostics, Medical Device, Nuclear Medicine, Biomarker, Lymphoma, Diagnostic Imaging, Nuclear Imaging Equipment, Point Of Care Testing, Stem Cell, Computed Tomography, Genome Sequencing, Leukemia.


 
1-10 of about 700 reports for Oncology

Purchase Reports From Reputable Market Research Publishers

Anesthesia Airway Management Devices - Medical Devices Pipeline Assessment, 2016

Anesthesia Airway Management Devices - Medical Devices Pipeline Assessment, 2016

  • $ 4000
  • Industry report
  • December 2016
  • by Global Data

Anesthesia Airway Management Devices - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Anesthesia Airway Management Devices - Medical Devices Pipeline Assessment, ...

Iclusig - ponatinib - Oncology drug report - 2013-2015 analysis; 2016-2021 expectations

Iclusig - ponatinib - Oncology drug report - 2013-2015 analysis; 2016-2021 expectations

  • $ 370
  • Industry report
  • December 2016
  • by Cancer Research Analytics

“Iclusig - ponatinib - Oncology drug report - 2013-2015 analysis; 2016-2021 expectations” is a comprehensive drug report on the most controversial drug in recent times. Iclusig is the first and only ...

Oncology drug report - Xalkori - crizotinib - 2011-2015 analysis; 2016-2021 expectations

Oncology drug report - Xalkori - crizotinib - 2011-2015 analysis; 2016-2021 expectations

  • $ 370
  • Industry report
  • December 2016
  • by Cancer Research Analytics

Xalkori: Strong start but competition ahead” is a comprehensive drug report about the market leader in ALK-positive metastatic NSCLC called Xalkori. Xalkori is the third-largest drug in Pfizer’s portfolio ...

Magnetic Resonance Imaging Systems - Medical Devices Pipeline Assessment, 2016

Magnetic Resonance Imaging Systems - Medical Devices Pipeline Assessment, 2016

  • $ 4000
  • Industry report
  • December 2016
  • by Global Data

Magnetic Resonance Imaging Systems - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Magnetic Resonance Imaging Systems - Medical Devices Pipeline Assessment, ...

Oncology drug report - Herceptin - trastuzumab - 2006-2015 analysis; 2016-2021 expectations

Oncology drug report - Herceptin - trastuzumab - 2006-2015 analysis; 2016-2021 expectations

  • $ 370
  • Industry report
  • November 2016
  • by Cancer Research Analytics

“Herceptin (trastuzumab): 2006-2015 analysis; 2016-2021 expectations” is a comprehensive report on the second-largest oncology drug by 2015 sales. Herceptin falls in the monoclonal antibody, HER2 inhibitor, ...

Oncology drug report - Revlimid - lenalidomide - 2005-2015 analysis; 2016-2021 expectations

Oncology drug report - Revlimid - lenalidomide - 2005-2015 analysis; 2016-2021 expectations

  • $ 500
  • Industry report
  • November 2016
  • by Cancer Research Analytics

Description “Oncology drug report - Revlimid - lenalidomide - 2005-2015 analysis; 2016-2021 expectations” is a comprehensive drug report on the fouth-largest oncology drug by 2015 sales. Revlimid is ...

Oncology drugs report - Neupogen and Neulasta - filgrastim franchise - 1991-2015 analysis; 2016-2021 expectations

Oncology drugs report - Neupogen and Neulasta - filgrastim franchise - 1991-2015 analysis; 2016-2021 expectations

  • $ 1000
  • Industry report
  • November 2016
  • by Cancer Research Analytics

“Oncology drugs report - Neupogen and Neulasta - filgrastim franchise - 1991-2015 analysis; 2016-2021 expectations” is a comprehensive report on Neupogen and Neulasta, two market leading drugs (by ...

Oncology drug report - Votrient - pazopanib - 2009-2015 analysis; 2016-2021 expectations

Oncology drug report - Votrient - pazopanib - 2009-2015 analysis; 2016-2021 expectations

  • $ 500
  • Industry report
  • November 2016
  • by Cancer Research Analytics

Description “Oncology drug report - Votrient - pazopanib - 2009-2015 analysis; 2016-2021 expectations” is a comprehensive report on multi-tyrosine kinase inhibitor targeted therapy drug Votrient’s ...

Oncology drug report - Adcetris - brentuximab vedotin - 2011-2015 analysis; 2016-2021 expectations

Oncology drug report - Adcetris - brentuximab vedotin - 2011-2015 analysis; 2016-2021 expectations

  • $ 500
  • Industry report
  • November 2016
  • by Cancer Research Analytics

“Adcetris: 2011-2015 analysis; 2016-2021 expectations” is a comprehensive report on the first and only approved drug of Seattle Genetics called Adcetris, which is also the first drug approved by the ...

Clovis Oncology Inc

Clovis Oncology Inc

  • $ 87
  • Company report
  • November 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Clovis Oncology Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses ...

About 25000 reports for Oncology

Download Unlimited Documents from Trusted Public Sources

Medical Facility Industry in the US

  • March 2015
    140 pages
  • Nursing Home  

    Hospital  

    Medical Center  

  • United States  

View report >

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.